Forbes March 9, 2020
Joshua Cohen

Precision medicine’s promise is to determine for each individual patient or subgroup if a drug will work or not, and whether it will produce adverse events. Among other pieces of information, it does this based on pharmacogenomics. Here, pharmacogenomics refers to how a person’s genetics affects his or her response to a drug. In this regard, an individual’s genetic makeup can determine how effective a medication will be, whether dosing changes will be needed, or whether a different medication should be prescribed.

MedImpact, the nation’s largest independent pharmacy benefit manager (PBM), is harnessing the technology of pharmacogenomics to systematically review prescriptions against a patient’s genetic profile. This highly personalized approach can reduce “trial and error” prescribing, reduce waste, lower the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Precision Medicine, Technology
Walgreens to help bring cell and gene therapies to patients as it expands specialty pharmacy services
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
STAT+: Amid layoffs and a hit to earnings, Bristol’s new CEO shares his vision for the future
Opinion: Shortages of generic drugs can’t be blamed solely on group purchasing organizations
Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss

Share This Article